Eva Boratto joins as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer joins as chief legal and compliance officer

Long Island City, New York, March 15, 2022 — Opentrons Labworks, Inc. today announced the appointment of Eva Boratto as Chief Financial Officer and a member of the Board of Directors and Veleka Peeples-Dyer as Chief Legal and Compliance Officer. The broad expertise and reach of Boratto and Peeples-Dyer enables the company to accelerate its strategic plans for growth and expansion in biotech automation, clinical diagnostics and synthetic biology.

Prior to joining Opentrons, Boratto served as Executive Vice President and Chief Financial Officer of CVS Health, Inc., a Fortune 5 company. During her tenure at CVS Health, she led the integration of the finance function following the company's 2018 acquisition of Aetna and most recently managed the company's financial performance during a business transformation accelerated by the COVID-19 pandemic. She brings more than 30 years of healthcare experience as a financial executive with a focus on organic and inorganic growth, financial performance, insightful analysis, and enhanced accountability and transparency. Prior to joining CVS Health, Boratto served as vice president and member of the U.S. markets executive leadership team at Merck, where he oversaw the more than $15 billion U.S. pharmaceutical market. She also serves as a member of the UPS Board of Directors and Audit Chair.

Peeples-Dyer is an accomplished attorney and executive with more than 22 years of legal and compliance experience working in the life sciences industry, advising pharmaceutical, biotechnology, medical device and other companies on behalf of the U.S. Food and Drug Administration (FDA) and global compliance matters. In addition to serving as strategic counsel to global life sciences clients at a prominent life sciences law firm, Peeples-Dyer serves as senior in-house legal and compliance counsel to leading companies, helping to develop and launch best-in-class products. Most recently, she served as chair of the North American Food and Drugs practice group at Baker McKenzie, a top global life sciences law firm. She is also a member of the firm's North American Healthcare and Life Sciences Steering Committee and has worked extensively with global law firms. cooperate. Healthcare and Life Sciences Team. Peeples-Dyer was recently named a 2022 “Most Influential Black Lawyer” by Savoy Magazine for the second time, one of many honors and recognitions she has received in the legal and life sciences fields.

"We are delighted to welcome Eva and Veleka to the team," said Jonathan Brennan-Badal, CEO of Opentrons. "Eva's proven track record in driving outcomes and deep understanding of healthcare positions Opentrons well as it brings our diagnostics Business unit expands beyond COVID-19 testing to ensure all individuals have equitable access to fast, accurate and low-cost diagnostics Veleka's leadership and strategic counsel for Opentrons. The expansion of growth and product development from research to commercialization is critical.”

About Opentrons Labworks, Inc.

Opentrons Labworks, Inc. is a disruptive life sciences company using its integrated laboratory platform to accelerate the pace of innovation in research and healthcare. Through our business unit Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use laboratory robots. Health systems across the United States rely on our Pandemic Response Laboratories (PRL) to provide high-throughput, affordable molecular diagnostic testing. Through the recent acquisitions of Neochromosome and Zenith AI, biopharmaceuticals can benefit from our world-class genome-scale cell engineering solutions. For more information, please visit https://www.opentronslabworks.com/.

Media Contact

Michael Sullivan